Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.46 Billion DKK | -50.37% |
| 2022 | 2.95 Billion DKK | 65.21% |
| 2021 | 1.78 Billion DKK | -29.99% |
| 2020 | 2.55 Billion DKK | 7.49% |
| 2019 | 2.37 Billion DKK | 1.02% |
| 2018 | 2.35 Billion DKK | 92.63% |
| 2017 | 1.22 Billion DKK | -11.14% |
| 2016 | 1.37 Billion DKK | 12.81% |
| 2015 | 1.21 Billion DKK | 2.1% |
| 2014 | 1.19 Billion DKK | -2.53% |
| 2013 | 1.22 Billion DKK | 325.88% |
| 2012 | 287.4 Million DKK | -7.08% |
| 2011 | 309.29 Million DKK | -1.58% |
| 2010 | 314.27 Million DKK | 4.05% |
| 2009 | 302.04 Million DKK | 7.79% |
| 2008 | 280.21 Million DKK | 6.71% |
| 2007 | 262.59 Million DKK | -8.4% |
| 2006 | 286.66 Million DKK | -7.19% |
| 2005 | 308.86 Million DKK | 13.99% |
| 2004 | 270.96 Million DKK | 3.45% |
| 2003 | 261.92 Million DKK | -6.21% |
| 2002 | 279.25 Million DKK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.53 Billion DKK | 5.36% |
| 2024 Q2 | 1.45 Billion DKK | 2.75% |
| 2024 Q1 | 1.41 Billion DKK | -3.34% |
| 2023 Q3 | 1.58 Billion DKK | -8.17% |
| 2023 Q1 | 2.88 Billion DKK | -2.37% |
| 2023 FY | 1.46 Billion DKK | -50.37% |
| 2023 Q4 | 1.46 Billion DKK | -7.45% |
| 2023 Q2 | 1.72 Billion DKK | -40.19% |
| 2022 Q1 | 2.38 Billion DKK | 33.17% |
| 2022 Q3 | 2.63 Billion DKK | 10.19% |
| 2022 Q4 | 2.95 Billion DKK | 11.94% |
| 2022 FY | 2.95 Billion DKK | 65.21% |
| 2022 Q2 | 2.39 Billion DKK | 0.59% |
| 2021 Q1 | 2.64 Billion DKK | 3.72% |
| 2021 Q3 | 1.66 Billion DKK | 14.14% |
| 2021 FY | 1.78 Billion DKK | -29.99% |
| 2021 Q2 | 1.45 Billion DKK | -45.0% |
| 2021 Q4 | 1.78 Billion DKK | 7.52% |
| 2020 Q1 | 2.55 Billion DKK | 7.45% |
| 2020 FY | 2.55 Billion DKK | 7.49% |
| 2020 Q2 | 2.48 Billion DKK | -2.55% |
| 2020 Q4 | 2.55 Billion DKK | 3.57% |
| 2020 Q3 | 2.46 Billion DKK | -0.88% |
| 2019 Q4 | 2.37 Billion DKK | 11.5% |
| 2019 Q1 | 2.38 Billion DKK | 1.53% |
| 2019 Q2 | 2.34 Billion DKK | -1.88% |
| 2019 FY | 2.37 Billion DKK | 1.02% |
| 2019 Q3 | 2.13 Billion DKK | -9.05% |
| 2018 FY | 2.35 Billion DKK | 92.63% |
| 2018 Q1 | 2.21 Billion DKK | 81.24% |
| 2018 Q3 | 2.36 Billion DKK | 0.0% |
| 2018 Q4 | 2.35 Billion DKK | -0.55% |
| 2018 Q2 | 2.36 Billion DKK | 6.87% |
| 2017 Q3 | 1.34 Billion DKK | -4.14% |
| 2017 FY | 1.22 Billion DKK | -11.14% |
| 2017 Q1 | 1.52 Billion DKK | 11.28% |
| 2017 Q2 | 1.4 Billion DKK | -8.31% |
| 2017 Q4 | 1.22 Billion DKK | -9.15% |
| 2016 Q1 | 1.33 Billion DKK | 9.28% |
| 2016 Q2 | 1.44 Billion DKK | 8.26% |
| 2016 Q3 | 1.27 Billion DKK | -11.31% |
| 2016 Q4 | 1.37 Billion DKK | 7.51% |
| 2016 FY | 1.37 Billion DKK | 12.81% |
| 2015 Q4 | 1.21 Billion DKK | -7.02% |
| 2015 FY | 1.21 Billion DKK | 2.1% |
| 2015 Q3 | 1.31 Billion DKK | -5.96% |
| 2015 Q2 | 1.39 Billion DKK | 8.74% |
| 2015 Q1 | 1.28 Billion DKK | 7.38% |
| 2014 Q1 | 1.25 Billion DKK | 2.45% |
| 2014 Q2 | 1.26 Billion DKK | 0.64% |
| 2014 Q4 | 1.19 Billion DKK | -6.28% |
| 2014 Q3 | 1.27 Billion DKK | 0.87% |
| 2014 FY | 1.19 Billion DKK | -2.53% |
| 2013 Q3 | 1.28 Billion DKK | -3.95% |
| 2013 FY | 1.22 Billion DKK | 325.88% |
| 2013 Q4 | 1.22 Billion DKK | -4.49% |
| 2013 Q2 | 1.33 Billion DKK | 315.8% |
| 2013 Q1 | 320.9 Million DKK | 11.66% |
| 2012 Q4 | 287.4 Million DKK | -21.26% |
| 2012 Q1 | 350.2 Million DKK | 13.22% |
| 2012 Q2 | 339.7 Million DKK | -3.0% |
| 2012 Q3 | 365 Million DKK | 7.45% |
| 2012 FY | 287.4 Million DKK | -7.08% |
| 2011 FY | 309.29 Million DKK | -1.58% |
| 2011 Q3 | 321 Million DKK | -8.18% |
| 2011 Q2 | 349.6 Million DKK | -4.77% |
| 2011 Q1 | 367.1 Million DKK | 16.81% |
| 2011 Q4 | 309.29 Million DKK | -3.65% |
| 2010 Q3 | 347.5 Million DKK | 0.26% |
| 2010 FY | 314.27 Million DKK | 4.05% |
| 2010 Q2 | 346.6 Million DKK | 5.48% |
| 2010 Q1 | 328.6 Million DKK | 8.79% |
| 2010 Q4 | 314.27 Million DKK | -9.56% |
| 2009 Q4 | 302.04 Million DKK | 0.0% |
| 2009 FY | 302.04 Million DKK | 7.79% |
| 2008 FY | 280.21 Million DKK | 6.71% |
| 2007 FY | 262.59 Million DKK | -8.4% |
| 2006 FY | 286.66 Million DKK | -7.19% |
| 2005 FY | 308.86 Million DKK | 13.99% |
| 2004 FY | 270.96 Million DKK | 3.45% |
| 2003 FY | 261.92 Million DKK | -6.21% |
| 2002 FY | 279.25 Million DKK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -7279.664% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -69116.242% |
| Össur hf. | 688.8 Million USD | -112.832% |
| QHSLab, Inc. | 2.05 Million USD | -71167.14% |
| Wellstar International, Inc. | 55.99 Million USD | -2518.299% |
| Össur hf. | 688.8 Million USD | -112.832% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -49622.844% |
| Aurora Spine Corporation | 6.65 Million USD | -21933.397% |
| BrainsWay Ltd. | 15.31 Million USD | -9472.94% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -8719.208% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -3097.883% |
| Vivos Inc. | 245 Thousand USD | -598257.578% |
| Kelyniam Global, Inc. | 1.01 Million USD | -144627.944% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -531803.314% |
| Zecotek Photonics Inc. | 5.86 Million USD | -24880.379% |
| Avitar, Inc. | 11.59 Million USD | -12544.977% |
| Nanomix Corporation | 14.81 Million USD | -9795.545% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -9016.612% |
| Theraclion SA | 13.01 Million EUR | -11162.569% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -72259.4% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -40384.153% |
| Lombard Medical, Inc. | 53.79 Million USD | -2625.211% |
| ALR Technologies Inc. | 24.5 Million USD | -5882.365% |
| Stratec SE | 271.97 Million USD | -439.029% |
| Vycor Medical, Inc. | 4.31 Million USD | -33852.68% |
| Heart Tronics, Inc. | 1.09 Million USD | -133807.082% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 41.039% |
| VMS Rehab Systems, Inc. | 201.36 USD | -728049164.998% |
| NewCardio, Inc. | 6.01 Million USD | -24281.94% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -26676.256% |
| Ingen Technologies, Inc. | 5.7 Million USD | -25576.293% |
| Odyssey Group International, Inc. | 6.61 Million USD | -22072.741% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -59741.424% |
| Wellness Center USA, Inc. | 5.12 Million USD | -28509.361% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -2134.961% |
| IR-Med Inc. | 634 Thousand USD | -231130.284% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -26668.599% |
| Polarean Imaging plc | 2.58 Million USD | -56709.837% |
| United American Healthcare Corporation | 119 Thousand USD | -1231832.773% |
| ECGI Holdings, Inc. | 11.94 Million USD | -12177.686% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -62050.615% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -110626.414% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -101259.503% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -216246.721% |
| Urologix, Inc. | 12.64 Million USD | -11494.432% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -27067.956% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -17182.732% |
| SS Innovations International, Inc. | 11.18 Million USD | -13011.409% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -278932.408% |
| Smith & Nephew plc | 4.76 Billion USD | 69.223% |
| NIOX Group Plc | 9.8 Million USD | -14855.979% |
| Fuse Medical, Inc. | 15.11 Million USD | -9602.142% |
| Broncus Holding Corporation | 10.43 Million USD | -13952.688% |
| Brain Scientific Inc. | 7.42 Million USD | -19640.378% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -4236.828% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -184515.927% |